secwatch.observer — SEC 8-K summary
======================================

Issuer:     LEXICON PHARMACEUTICALS, INC. (LXRX)
CIK:        0001062822
Form:       8-K
Filed at:   2023-06-02T23:59:59+00:00
Accession:  0001193125-23-159886
Event type: other_material
Sentiment:  neutral
Materiality: 0.75
Item codes: 1.01, 3.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Lexicon raises $125M in public offering and private placement to fund INPEFA launch
--------------------------------------------------------------------------------

- Public offering of 23,924,705 shares at $2.60/share, gross $62.2M.
- Concurrent private placement of 24,152,218 shares at $2.60/share to Invus affiliate, gross $62.8M.
- Underwriters' option and private placement option fully exercised; total gross proceeds ~$125M.
- Proceeds to fund commercial launch of INPEFA (sotagliflozin) and R&D.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1062822/000119312523159886/0001193125-23-159886-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1062822/000119312523159886/d512290d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-159886

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer